Reuters: Private Equity: RPT-Chr Hansen main owner completes sale to Novo fund

Reuters: Private Equity Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

RPT-Chr Hansen main owner completes sale to Novo fund Mar 29th 2012, 10:22 Thu Mar 29, 2012 6:22am EDT COPENHAGEN, March 29 (Reuters) - The biggest shareholder in Danish food ingredients maker Chr. Hansen has sold a 25.7 percent stake to Novo A/S, cutting its holdings to 0.09 percent in line with a January announcement, Chr. Hansen said on Thursday. Financiere Star 1 S.A., a fund controlled by private equity investment firm PAI Partners, sold about 35.42 million shares in Chr. Hansen Holding A/S to Novo A/S, Chr. Hansen said. The companies had announced the deal on Jan. 11. . Novo A/S is a foundation-owned company and the main shareholder in Danish drugmaker Novo Nordisk A/S and industrial enzymes maker Novozymes A/S. Novo A/S said in January it aimed to be a long-term minority shareholder in Chr. Hansen and had no intention to take control of the company. (Reporting by John Acher, editing by Kristian Balsgaard Mortensen)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions